First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation

Fertil Steril. 2008 Oct;90(4):1206-10. doi: 10.1016/j.fertnstert.2007.08.050. Epub 2007 Dec 27.

Abstract

We retrospectively compared the first trimester Down's syndrome serum screening markers free beta-hCG (fbetahCG) and pregnancy-associated plasma protein-A (PAPP-A) at 11-14 weeks of gestation in 4,088 women with naturally conceived pregnancies and in women pregnant after ICSI (n = 163), IVF (n = 59) and frozen-thawed embryo transfer (n = 31), and we searched for a potential relationship between infertility cause and marker levels. We found lower serum PAPP-A levels in pregnancies after IVF and ICSI compared with spontaneously conceived pregnancies and non-male factor infertility was associated with elevated serum fbetahCG levels at 11-14 weeks of gestation.

MeSH terms

  • Adult
  • Belgium / epidemiology
  • Biomarkers / blood
  • Chorionic Gonadotropin, beta Subunit, Human / blood*
  • Down Syndrome / blood
  • Down Syndrome / diagnosis*
  • Down Syndrome / embryology
  • Down Syndrome / epidemiology*
  • Female
  • Humans
  • Incidence
  • Infertility, Female / blood*
  • Infertility, Female / diagnosis
  • Infertility, Female / epidemiology*
  • Mass Screening / methods
  • Mass Screening / statistics & numerical data*
  • Pregnancy
  • Pregnancy Trimester, First / blood
  • Prenatal Diagnosis / methods
  • Prenatal Diagnosis / statistics & numerical data*
  • Retrospective Studies
  • Risk Assessment / methods
  • Risk Factors

Substances

  • Biomarkers
  • Chorionic Gonadotropin, beta Subunit, Human